Cargando…

Effect of statins on inflammation and cardiac function in patients with chronic Chagas disease: A protocol for pathophysiological studies in a multicenter, placebo-controlled, proof-of-concept phase II trial

BACKGROUND: Cardiac complications, including heart failure and arrhythmias, are the leading causes of disability and death in Chagas disease (CD). CD, caused by the Trypanosoma cruzi parasite, afflicts 7 million people in Latin America, and its incidence is increasing in non-endemic countries due to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campos-Estrada, Carolina, Urarte, Edurne, Denegri, Marisol, Villalón, Litzi, González-Herrera, Fabiola, Kemmerling, Ulrike, Maya, Juan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838836/ https://www.ncbi.nlm.nih.gov/pubmed/36638112 http://dx.doi.org/10.1371/journal.pone.0280335

Ejemplares similares

Simvastatin Improves Cardiac Function through Notch 1 Activation in BALB/c Mice with Chronic Chagas Cardiomyopathy
por: Guzmán-Rivera, Daniela, et al.
Publicado: (2020)

Proof of Concept of a Novel Multiepitope Recombinant Protein for the Serodiagnosis of Patients with Chagas Disease
por: Machado, Juliana Martins, et al.
Publicado: (2023)

A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease
por: Torrico, Faustino, et al.
Publicado: (2022)

Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin
por: Campos-Estrada, Carolina, et al.
Publicado: (2015)

Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease
por: Carrillo, Ileana, et al.
Publicado: (2021)

Reorganization of Extracellular Matrix in Placentas from Women with Asymptomatic Chagas Disease: Mechanism of Parasite Invasion or Local Placental Defense?
por: Duaso, Juan, et al.
Publicado: (2012)

Unraveling the pathophysiology of lower-limb postthrombotic syndrome in adolescents: a proof-of-concept study
por: Avila, M. Laura, et al.
Publicado: (2023)

Stroke in Chagas disease: from pathophysiology to clinical practice
por: Lage, Thaís Aparecida Reis, et al.
Publicado: (2022)

Western blot using Trypanosoma cruzi chimeric recombinant proteins for the serodiagnosis of chronic Chagas disease: A proof-of-concept study
por: Daltro, Ramona Tavares, et al.
Publicado: (2022)

Statins change the cytokine profile in Trypanosoma cruzi-infected U937 macrophages and murine cardiac tissue through Rho-associated kinases inhibition
por: González-Herrera, Fabiola, et al.
Publicado: (2023)

Correlates of Post-Stroke Brain Plasticity, Relationship to Pathophysiological Settings and Implications for Human Proof-of-Concept Studies
por: Sanchez-Mendoza, Eduardo H., et al.
Publicado: (2016)

Pathophysiology and new targets for therapeutic options in Chagas heart disease
por: Ferreira, João Marcos B Barbosa
Publicado: (2022)

Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept
por: Kaddurah-Daouk, R, et al.
Publicado: (2011)

Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer’s disease
por: Cummings, Jeffrey L., et al.
Publicado: (2016)

Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients
por: Cramer, Steven C., et al.
Publicado: (2017)

Proof of Concept, Randomized, Placebo-Controlled Study of the Effect of Simvastatin on the Course of Age-Related Macular Degeneration
por: Guymer, Robyn H., et al.
Publicado: (2013)

A Phase 2 Proof‐of‐Concept, Randomized, Placebo‐Controlled Trial of CX‐8998 in Essential Tremor
por: Papapetropoulos, Spyros, et al.
Publicado: (2021)

Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
por: Kahaly, George J, et al.
Publicado: (2023)

The Versatile Transceiver Proof of Concept
por: Troska, J, et al.
Publicado: (2009)

Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome-a preliminary proof of concept
por: Orvieto, Raoul, et al.
Publicado: (2014)

Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use
por: Baltatu, Ovidiu Constantin, et al.
Publicado: (2019)

Statin tolerability: In defence of placebo-controlled trials
por: Tobert, Jonathan A, et al.
Publicado: (2015)

Old Yellow Enzyme from Trypanosoma cruzi Exhibits In Vivo Prostaglandin F(2)α Synthase Activity and Has a Key Role in Parasite Infection and Drug Susceptibility
por: Díaz-Viraqué, Florencia, et al.
Publicado: (2018)

The LHCb Grid simulation: Proof of concept
por: Hushchyn, M, et al.
Publicado: (2017)

DNA watermarks: A proof of concept
por: Heider, Dominik, et al.
Publicado: (2008)

Groupness in Preverbal Infants: Proof of Concept
por: Bradley, Benjamin Sylvester, et al.
Publicado: (2017)

Current concepts in the pathophysiology of glaucoma
por: Agarwal, Renu, et al.
Publicado: (2009)

Pathophysiological Concepts and Treatment of Camptocormia
por: Margraf, N.G., et al.
Publicado: (2016)

Sepsis—Pathophysiology and Therapeutic Concepts
por: Jarczak, Dominik, et al.
Publicado: (2021)

Soluble Biomarkers of Cartilage and Bone Metabolism in Early Proof of Concept Trials in Psoriatic Arthritis: Effects of Adalimumab Versus Placebo
por: van Kuijk, Arno W. R., et al.
Publicado: (2010)

A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
por: Toniolo, Ricardo Alexandre, et al.
Publicado: (2017)

Chronic Chagas cardiomyopathy
por: Aiello, Vera Demarchi, et al.
Publicado: (2015)

SLCO1B1 Genetic Variant Associated With Statin-Induced Myopathy: A Proof-of-Concept Study Using the Clinical Practice Research Datalink
por: Carr, D F, et al.
Publicado: (2013)

Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
por: Koblan, Kenneth S, et al.
Publicado: (2015)

Relieving acute pain (RAP) study: a proof-of-concept protocol for a randomised, double-blind, placebo-controlled trial
por: Colloca, Luana, et al.
Publicado: (2019)

Efficacy and Safety of ASP0819 in Patients with Fibromyalgia: Results of a Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
por: Arnold, Leslie M, et al.
Publicado: (2020)

Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Outpatient Treatment of Mild Coronavirus Disease (COVID-19)
por: McCreary, Marvin R., et al.
Publicado: (2021)

An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study
por: Sen, Arjune, et al.
Publicado: (2021)

Randomized double-blind placebo-controlled proof-of-concept trial of resveratrol for outpatient treatment of mild coronavirus disease (COVID-19)
por: McCreary, Marvin R., et al.
Publicado: (2022)

Proof-of-concept studies in Yoga and mental health
por: Bharadwaj, Balaji
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_jbldl9rrotj1ck3jfkssd8s8c7